| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +12% |
| 3Y CAGR | +12% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +16% |
| 3Y CAGR | -13% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,357.20 +20.80 (0.89%) | 17,770.39 | 26.21 | 5.27 | ||
PfizerPFIZER | ₹3,680.50 +41.80 (1.15%) | 16,642.57 | 22.64 | 3.96 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,327.50 +36.00 (0.57%) | 15,708.13 | 92.61 | 18 | ||
Natco PharmaNATCOPHARM | ₹785.10 -0.65 (0.08%) | 15,419.78 | 13.47 | 1.47 |